Doximity Inc
NYSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Doximity Inc
NYSE:DOCS
|
US |
|
Eurocommercial Properties NV
AEX:ECMPA
|
NL |
|
Frontier Digital Ventures Ltd
ASX:FDV
|
MY |
|
Vallianz Holdings Ltd
SGX:WPC
|
SG |
|
O
|
OsstemImplant Co Ltd
KOSDAQ:048260
|
KR |
|
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
CA |
|
Acrow Formwork and Construction Services Ltd
ASX:ACF
|
AU |
Wall Street
Price Targets
DOCS Price Targets Summary
Doximity Inc
According to Wall Street analysts, the average 1-year price target for
DOCS
is 41.59 USD
with a low forecast of 25.25 USD and a high forecast of 63 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DOCS's stock price target?
Price Target
41.59
USD
According to Wall Street analysts, the average 1-year price target for
DOCS
is 41.59 USD
with a low forecast of 25.25 USD and a high forecast of 63 USD.
What is Doximity Inc's Revenue forecast?
Projected CAGR
10%
For the last 5 years the
compound annual growth rate for
Doximity Inc's revenue is
37%.
The projected
CAGR
for the next 4 years is
10%.
What is Doximity Inc's Operating Income forecast?
Projected CAGR
21%
For the last 5 years the
compound annual growth rate for
Doximity Inc's operating income is
60%.
The projected
CAGR
for the next 4 years is
21%.
What is Doximity Inc's Net Income forecast?
Projected CAGR
13%
For the last 5 years the
compound annual growth rate for
Doximity Inc's net income is
83%.
The projected
CAGR
for the next 4 years is
13%.
